Recombinant glycoprotein B vaccine formulation with Toll-like receptor 9 agonist and immune-stimulating complex induces specific immunity against multiple strains of cytomegalovirus.

Source:http://linkedlifedata.com/resource/pubmed/id/21307228

Download in:

View as

General Info

PMID
21307228